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Highlights 
 
 Gamma oscillations are synchronised by parvalbumin positive interneurons 
 Gamma band responses to tasks were reduced in psychosis and at risk populations 
 Artefacts occurring within the gamma band have not been adequately addressed 
 Longitudinal studies with larger sample sizes, addressing sources of bias are needed 
 
Abstract 
Abnormal gamma oscillations, measured by electroencephalography (EEG), have 
been associated with chronic psychotic disorders, but their prevalence in the early 
phase of psychosis is less clear. We sought to address this issues by systematically 
reviewing the relevant literature. We searched for EEG studies of gamma band 
oscillations in subjects at high risk for psychosis and in patients with first episode 
psychosis. The following measures of gamma oscillations were extracted: resting 
power, evoked power, induced power, connectivity and peak frequency. Forty-five 
studies with a total of 3099 participants were included. There were potential sources 
of bias in the study designs and potential artefacts. Although there were few 
consistent findings, several studies reported decreased evoked or induced power in 
both high risk subjects and first episode patients. Studies using larger samples with 
serial EEG measurements, and designs that minimise artefacts that occur at the 
gamma frequency may advance work in this area. 
 
Keywords 
Psychotic Disorders; Schizophrenia; Neurophysiology; Electroencephalography; 
Gamma Rhythm; Review, Systematic. 
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1. Introduction 
Gamma oscillations, with a frequency of 30-130Hz, have been proposed as a 
mechanism linking neural dysfunction to the symptoms of psychosis (McNally and 
McCarley 2016). These oscillations are generated through the synchronised 
activation of pyramidal neuronal assemblies in the cerebral cortex (Fries, Nikolic et 
al. 2007), a process co-ordinated by an inhibition and rebound excitation cycle 
mediated by the effects of GABAergic, fast spiking interneurons acting on GABA-A 
receptors (Bartos, Vida et al. 2007). Glutamatergic afferents at NMDA receptors 
provide excitatory input to these interneurons (Bartos, Vida et al. 2007). Gamma 
oscillations are well conserved across species (Buzsaki, Logothetis et al. 2013) and 
are thought to be fundamental for normal cortico-cortical communication, and 
cognitive functioning (Fries 2009, Roux, Wibral et al. 2012).  
 
There are multiple paradigms that can be used to measure gamma band oscillations. 
These include the acquisition of data in the resting state, or in the form of evoked 
(time-locked and phase-locked to a stimulus), or induced (time-locked to a stimulus 
only) responses (Roach and Mathalon 2008). Stimuli can be presented in a variety of 
different sensory modalities, but are usually visual or auditory. These may be 
presented as steady state responses (e.g. click trains), oddball stimuli or via a 
cognitive task. Several features of gamma band oscillations can be measured 
including their power (amplitude of the waveform, squared), functional connectivity 
(such as coherence or phase synchrony), and peak frequency within the gamma 
band. Various factors can potentially modify gamma band oscillations. Linguistic 
stimuli presented using native versus non-native language, for example, affect the 
gamma band response (Kosem and Wassenhove 2017), as does the level of the 
participant’s attention to the stimulus (Bauer, Stenner et al. 2014). For visual tasks, 
large high contrast grating stimuli tend to produce gamma responses with highest 
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amplitude (Hermes, Miller et al. 2015). Additionally, multiple pharmacological agents 
can affect gamma oscillations, including antipsychotics (Alegre, Molero et al. 2017), 
stimulants (Berke 2009), ketamine (Vlisides, Bel-Bahar et al. 2017), and 
cannabinoids (Nottage, Stone et al. 2015). 
 
In post mortem studies of schizophrenia, decreased levels of glutamic acid 
decarboxylase (crucial for GABA synthesis) have been observed in parvalbumin-
positive basket cells (Lewis 2014), a class of GABAergic interneurons that play a 
major role in the production of gamma oscillations (Buzsaki and Wang 2012). It has 
been suggested that dysfunction of parvalbumin-positive interneurons, via 
hypofunction of the NMDA receptor leads to abnormal gamma band oscillations in 
schizophrenia (Gonzalez-Burgos, Cho et al. 2015), illustrated diagrammatically in 
Figure 1. Dysfunction of this rhythmic activity has thus been suggested as a 
mechanism for how abnormal neural circuits could lead to the widespread 
impairments in cognitive function that are seen in patients with schizophrenia (Lesh, 
Niendam et al. 2011). There have been multiple reports of abnormal gamma 
oscillations in patients with chronic schizophrenia (Rutter, Carver et al. 2009, 
Grutzner, Wibral et al. 2013, Chen, Stanford et al. 2014, Hirano, Oribe et al. 2015). 
The extent to which these findings are related to illness chronicity or the effects of 
long term treatment with antipsychotic medication are unclear. These issues can be 
addressed by studying gamma band abnormalities in subjects who have recently 
developed a first episode of psychosis, and have received relatively little treatment.  
 
It is possible that changes in gamma band oscillations reflect pathophysiological 
changes that are associated with the development of psychosis, and may therefore 
be evident in subjects who are at high risk for the disorder. The assessment of 
gamma band oscillations in individuals who are at high risk but have not yet 
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developed a psychotic disorder provides an opportunity to prospectively examine 
their role in the onset of illness. People who meet criteria for the Clinical High Risk 
(CHR) state typically present with attenuated psychotic symptoms in the context of a 
functional decline, and up to 30% of this group will develop a first episode of 
psychosis within two years (Fusar-Poli, Bonoldi et al. 2012). People with a first 
degree relative who has a psychotic illness, such as schizophrenia, are also at 
increased risk of the disorder; with a risk that is 8-10 times greater than that in the 
general population, but over their entire lifetime, as opposed to the next two years 
(O'Donovan, Craddock et al. 2009). As they do not have a psychotic disorder but 
share genetic susceptibility with those who do, subjects at familial high risk may 
provide endophenotypes, measures of inherited vulnerability (Gottesman and Gould 
2003). A third group at increased risk of psychosis are people with schizotypy, 
personality traits that are qualitatively similar to some features of schizophrenia. 
These traits are thought to reflect an underlying liability for psychosis (Debbane and 
Barrantes-Vidal 2015), though the relationship between schizotypal traits and the risk 
of subsequently developing psychosis is unclear, with large variations in incidence 
(Debbane, Eliez et al. 2015).  
 
The aim of this review is to critically evaluate the evidence for gamma band 
abnormalities in the early phase of psychosis. Due to the wide variety in the methods 
that have been used to measure gamma band oscillations in the literature, we 
adopted a broad approach: we included all studies quantifying any features of these 
oscillations in subjects at increased risk for psychosis (CHR, familial risk and 
schizotypy) or patients with first episode psychosis. We extracted differences in 
gamma power, frequency and connectivity between these groups and healthy 
controls. 
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2. Methods 
2.1. Search Criteria 
We searched the following databases, from inception to January 2017: MEDLINE, 
EMBASE, PsychINFO. The following combination of search terms was used: EEG 
AND ((psychosis OR psychotic OR schizophrenia) AND (risk OR prodrom* OR 
predict OR first episode)) OR schizotypy). Additionally, references of selected studies 
were manually searched. The search was performed independently by two 
investigators (TR and ADM). We first examined study titles and abstracts, obtaining 
full text articles for all studies which were potentially relevant before deciding whether 
to include. 
 
2.2 Selection Criteria 
We included original research, in English language only, which used human subjects. 
Studies were included if they reported measures of oscillations within the gamma 
band (30-130 Hz) using EEG. We included the following populations:  
 First episode psychosis, which could include schizophrenia, schizoaffective 
disorder, schizophreniform disorder, psychotic disorder not otherwise 
specified, bipolar affective disorder with psychotic symptoms or depressive 
disorder with psychotic symptoms, based on either ICD-10 or DSM criteria. 
‘First episode’ was based on the study author’s own definition, which could 
include, for example, patients undergoing their first hospitalisation for 
psychosis, or psychotic symptoms presenting for the first time in the past 24 
months. 
 CHR for psychosis, defined using diagnostic criteria based on a valid clinical 
tool such as Criteria for Prodromal Syndrome, Basel Screening Instrument for 
Psychosis, or Structured Interview for Prodromal Syndrome.  
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 Familial risk, defined as having a first degree relative with a diagnosis of 
schizophrenia or schizoaffective disorder. 
 Schizotypy, defined as populations with measures of schizotypy (such as the 
Schizotypal Personality Disorder Questionnaire), or those with schizotypal 
personality disorder based on DSM or ICD-10 criteria. 
 
We excluded reviews, conference abstracts, animal studies, studies using only MEG 
and studies which measured Event Related Potentials (ERPs) or oscillations outwith 
the gamma band. We excluded studies of participants with psychotic disorders who 
were not in their first episode or first hospitalisation. We made no restriction as to 
what aspect of gamma oscillations were measured and therefore included studies 
reporting resting, induced and evoked power, functional connectivity and peak 
gamma frequency. We included overlapping data-sets if they measured different 
aspects of gamma oscillations. 
 
2.3 Data Extraction 
We recorded the following variables from each article: author, year of publication, 
study population, task used to produce gamma oscillations and quality of each study. 
We also extracted all measures of gamma oscillations: resting power, evoked power, 
induced power, functional connectivity and peak frequency. We recorded whether 
subjects experiencing their first episode of psychosis were exposed to antipsychotic 
medication. This was done by two authors (TR and ADM), with disagreement 
resolved by discussion. Effect sizes in the form of Hedge’s g were calculated where 
possible to correct for bias from small sample sizes.  
 
2.4 Assessment of Bias 
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We assessed risk of bias using a modified version of the Newcastle-Ottawa scale 
(see Appendix) for the evaluation of non-randomised studies (Stang 2010). The scale 
evaluates the quality of reporting. According to this tool, every study is judged on 
three broad categories: the selection of the study groups; the comparability of the 
groups; and the ascertainment of either the exposure or outcome of interest. We 
adapted this scale by rating selection of cases as 1 if a validated diagnostic 
instrument was used and 0 if not. We also rated ascertainment of gamma 1 if this 
was done blindly in regard to case-control status and 0 if not. In total, a study could 
score between 0-9, from lowest to highest quality. We also recorded whether the 
following gamma artefacts had been addressed: power line noise, muscle artefact 
and saccadic artefact. This was scored from 0-3; we did not score artefact removal 
which was done by a voltage threshold or manually through visual inspection. 
 
3. Results 
45 studies were included, see PRISMA flow-chart Figure 2, comprising a total of 
3099 participants. Of these, 42 were independent datasets, as there were 3 pairs of 
overlapping samples (Kikuchi, Koenig et al. 2007, and Kikuchi, Hashimoto et al. 
2011, Tcheslavski 2008, and Tcheslavski and Beex 2010, Ramyead, Kometer et al. 
2015, and Ramyead, Studerus et al. 2015). 17 studies included first episode patients, 
5 were of CHR, 14 were of people at familial risk, 8 were of schizotypy and one study 
(Tada, Nagai et al. 2014) included both CHR and first episode patients. The 
measures of gamma oscillations included are described in Table 1. 
 
3.1 First Episode Psychosis  
Studies involving patients with first episode psychosis are shown in Table 2. These 
comprised a total of 1125 participants; 522 patients and 603 healthy controls. Most 
patients had a diagnosis of schizophrenia, defined by DSM-IV criteria in 11 studies 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 9 
(Gallinat, Winterer et al. 2004, Yeragani, Cashmere et al. 2006, Kikuchi, Koenig et al. 
2007, Flynn, Alexander et al. 2008, Spencer, Salisbury et al. 2008, Williams, Whitford 
et al. 2009a, Williams, Whitford et al. 2009b, Minzenberg, Firl et al. 2010, Kikuchi, 
Hashimoto et al. 2011, Taylor, McCarley et al. 2013, Tada, Nagai et al. 2014), ICD-
10 criteria in 3 (Tikka, Yadav et al. 2014, Garakh, Zaytseva et al. 2015, Ramyead, 
Studerus et al. 2016), and a composite of these in 4 (Slewa-Younan, Gordon et al. 
2004, Symond, Harris et al. 2005, Andreou, Nolte et al. 2015, Leicht, Andreou et al. 
2015). Five studies were of participants who were naïve to antipsychotic medication 
(Kikuchi, Koenig et al. 2007, Kikuchi, Hashimoto et al. 2011, Ramyead, Studerus et 
al. 2016, Tikka, Yadav et al. 2014, Yeragani, Cashmere et al. 2006). 
 
Seven first episode studies utilised resting state paradigms: of these, 4 measured 
gamma power. Compared with healthy controls, power was increased in one study 
(Tikka, Yadav et al. 2014), but in 3 there were no significant group differences 
(Yeragani, Cashmere et al. 2006, Andreou, Nolte et al. 2015, Garakh, Zaytseva et al. 
2015). Increased current source density activity in the left medial frontal gyrus was 
reported in one study (Ramyead, Studerus et al. 2016).  
 
One study (Kikuchi, Koenig et al. 2007) reported that patients showed increased 
gamma global field synchronisation. Another described decreased mean coherence 
of spectral power between C4 and F4 electrodes (Yeragani, Cashmere et al. 2006), 
and a trend for reduced mean phase between C4 and F4. Other studies reported 
increased orthogonalised power envelope correlation (Andreou, Nolte et al. 2015), 
and increased omega complexity (Kikuchi, Hashimoto et al. 2011), respectively. 
  
Auditory oddball tasks were used in 6 first episode studies. Evoked power was 
decreased in one (Taylor, McCarley et al. 2013). In another, there was no overall 
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difference, although there was a decrease in the right frontal region (Gallinat, 
Winterer et al. 2004). Four studies measured gamma phase synchrony; 3 (Slewa-
Younan, Gordon et al. 2004, Symond, Harris et al. 2005, Williams, Whitford et al. 
2009a) showed a decrease in synchrony, while one (Flynn, Alexander et al. 2008) 
showed an increase. The latency of gamma phase synchrony was found to be 
increased in the study by Slewa-Younan, Gordon et al. (2004), but decreased in the 
study by Symond, Harris et al. (2005). Decreased inter-trial phase locking was 
reported in the study by Taylor, McCarley et al. (2013). 
 
Two first episode studies measured auditory steady state responses. One reported 
decreased evoked power and phase locking factor in both patients with 
schizophrenia and patients with affective psychosis (Spencer, Salisbury et al. 2008). 
The other reported decreased induced power and inter-trial phase coherence in 
schizophrenia (Tada, Nagai et al. 2014). 
 
An auditory reaction task demonstrated decreased power and phase-locking factor in 
first episode schizophrenia (Leicht, Andreou et al. 2015). Similarly, induced power 
was decreased in response to a preparatory cognitive control task, Preparing to 
Overcome Prepotency (Minzenberg, Firl et al. 2010). Increased phase synchrony in 
first episode schizophrenia was described in a study of an emotion perception task 
(Williams, Whitford et al. 2009b).  
 
One study examined gamma synchrony in relation to volumetric MRI data in 13 first 
episode participants (Williams, Whitford et al. 2009a), reporting that patients showed 
an inverse relationship between gamma synchrony and grey matter volume in right 
temporal and parieto-occipital regions.  
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3.2 Clinical High Risk 
Studies of CHR subjects are shown in Table 3. These comprised a total of 370 
participants; 229 at risk of psychosis and 141 healthy controls. 3 studies used resting 
EEG, although 2 of these (Ramyead, Kometer et al. 2015, Ramyead, Studerus et al. 
2015) used the same dataset. The first reported an increase in spontaneous power in 
the medial prefrontal cortex in CHR patients who later developed psychosis, 
compared with healthy controls. Machine learning was then applied to this dataset in 
the second study. Predictions of transition were made using current source density in 
the gamma and beta bands, with an internally cross-validated area under the 
receiver operating characteristic curve (AUC) of 0.77. By contrast, Andreou, Leicht et 
al. (2015) found no differences in spontaneous power or resting connectivity in CHR, 
as quantified by the multivariate interaction measure. 
 
Perez, Roach et al. (2013) used an auditory reaction task was used to measure 
evoked power, total power and phase locking factor. Evoked power was reduced in 
CHR subjects, whereas total power showed no difference, and there was a trend for 
phase locking factor to be decreased (p=0.057). Leicht, Vauth et al. (2016) used an 
auditory reaction task to investigate gamma power, peak frequency and phase 
locking factor. Evoked power and peak frequency were decreased, while there was 
no difference in latency of peak gamma response between groups. Phase locking 
factor was decreased, though this did not reach statistical significance (p=0.092). 
Tada, Nagai et al. (2014) used an auditory steady state response paradigm to 
measure induced power and inter-trial phase coherence, both of which were 
decreased in the CHR group. 
 
Leicht, Vauth et al. (2016) simultaneously recorded EEG and fMRI while participants 
performed a cognitively demanding auditory reaction task. Evoked gamma power 
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peaks were coupled with BOLD signal. There was significantly reduced activation of 
a network which included bilateral auditory cortices, the thalamus anterior cingulate 
cortex and dorsolateral prefrontal cortex in the CHR group.  
   
3.3 Familial High Risk 
Most of these studies have examined the unaffected relatives of patients with 
schizophrenia, as shown in Table 4, apart from Hong, Summerfelt et al. (2004) who 
recruited relatives of patients who also had schizophrenia spectrum personality traits. 
In total, 1381 participants were included; 640 at familial risk and 741 controls with a 
negative family history. 
 
Resting EEG was used in 5 studies. Increased spontaneous power was reported by 
Bandyopadhyaya, Nizamie et al. (2011), and Tikka, Nizamie et al. (2015), but no 
difference in power was found by Winterer, Egan et al. (2001), Hong, Summerfelt et 
al. (2012). Venables, Bernat et al. (2009) found no group differences with ‘eyes 
closed’, but increased spontaneous power in familial high risk subjects with ‘eyes 
open’. In terms of coherence, Bandyopadhyaya, Nizamie et al. (2011) reported 
decreased spectral coherence at rest, while Tikka, Nizamie et al. (2015) found no 
differences in inter or intra hemispheric spectral coherence. 
 
Auditory oddball tasks were used in 4 studies. Increased frontal noise power was 
reported by Winterer, Coppola et al. (2004), whereas Diez, Suazo et al. (2013) found 
no difference in gamma noise magnitude. Decreased evoked spectral power was 
reported in unaffected monozygotic twins of schizophrenia patients (Hall, Taylor et al. 
2011a). Phase locking factor was also decreased but did not reach statistical 
significance. No differences were reported in total spectral power by Diez, Suazo et 
al. (2014). 
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Paired auditory clicks were used to examine power, showing decreased evoked 
power in response to the first stimuli and an increased response to the second stimuli 
(Hall, Taylor et al. 2011b). However, neither difference was statistically significant. 
Another paired auditory click paradigm showed no difference in power between 
groups (Hong, Summerfelt et al. 2012). 
 
Auditory state responses were used by Hong, Summerfelt et al. (2004), and Rass, 
Forsyth et al. (2012), both showed decreased power in those at familial risk. 
Decreased phase locking factor was also reported by Rass, Forsyth et al. (2012). An 
auditory reaction task showed decreased evoked power and decreased phase 
locking factor in unaffected siblings of schizophrenia patients (Leicht, Karch et al. 
2011). 
 
3.4 Schizotypy 
Eight studies examined gamma in relation to schizotypy, comprising a total of 223 
participants (Table 5). Five studies (Vernon, Haenschel et al. 2005, Tcheslavski 
2008, Tcheslavski and Beex 2010, Koychev, Deakin et al. 2011, Fuggetta, Bennett et 
al. 2014) divided healthy volunteers into two groups based on their scores on a 
schizotypy scale, 2 (Skosnik, Krishnan et al. 2006, Kornmayer, Leicht et al. 2015) 
correlated measures of gamma with schizotypy scores of healthy volunteers and one 
(Brenner, Sporns et al. 2003) compared people with schizotypal personality disorder 
to healthy controls. The Schizotypy Personality Questionnaire (Raine 1991) was 
used to measure schizotypy in 7 studies (Vernon, Haenschel et al. 2005, Skosnik, 
Krishnan et al. 2006, Tcheslavski 2008, Tcheslavski and Beex 2010, Koychev, 
Deakin et al. 2011, Kornmayer, Leicht et al. 2015), while Fuggetta, Bennett et al. 
(2014) used the Unusual Experiences and Cognitive Disorganisation sub scales of 
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the Oxford-Liverpool Inventory of Feelings and Experiences (Mason and Claridge 
2006).  
 
In the resting state, Fuggetta, Bennett et al. (2014) reported decreased spontaneous 
power in subjects with high schizotypy (though this was not statistically significant), 
while Tcheslavski (2008) reported increased power and Tcheslavski and Beex (2010) 
reported increased phase synchrony. 
 
There was no difference in evoked power from auditory steady state response in 
subjects with schizotypal personality disorder compared with healthy controls 
(Brenner, Sporns et al. 2003). Skosnik, Krishnan et al. (2006) described a negative 
correlation of schizotypal scores with evoked power using auditory steady state 
responses, while positive correlation of visually evoked power with schizotypy scores 
was reported by Kornmayer, Leicht et al. (2015). 
 
Using a visual working memory task, Koychev, Deakin et al. (2011) found that high 
versus low schizotypy was associated with increased evoked power and decreased 
phase locking factor in fronto-central and central-occipital regions. Increased evoked 
power and decreased phase locking factor was seen in high schizotypy compared 
with low schizotypy in fronto-central and central-occipital regions. Vernon, Haenschel 
et al. (2005) used an auditory habituation task to show that individuals with high 
versus low unreality schizotypy scores had decreased spectral power in the central 
posterior region, but this was not statistically significant. 
 
3.5 Relationship with Psychopathology 
Thirteen studies examined the relationship between gamma oscillations and 
psychopathology; 10 in patients with first episode psychosis, 2 in those at CHR and 
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one using both groups. Tikka, Nizamie et al. (2015) reported a negative correlation 
between low gamma power (30-50Hz) in the left temporal region and Positive and 
Negative Syndrome Scale (PANSS) general psychopathology subscale (r=0.427 
p<0.05); a positive correlation between high gamma power (70-100Hz) in the right 
occipital region and the PANSS general psychopathology subscale; and a negative 
correlation between PANSS total scores and left temporal gamma power at both 30-
50Hz (r=0.473 p<0.01) and at 50-70Hz (r=0.389 p<0.05).  
 
Taylor, McCarley et al. (2013) reported positive correlations of phase locking factor 
and PANSS total scores at Fz (r=0.47 p=0.024) and Cz (r=0.43 p=0.004). They also 
reported positive correlation of PANSS total scores and power at Fz (r=0.71 p<0.001) 
and Cz (r=0.61 p=0.002). There were trends for positive correlations between power 
at Fz and PANSS positive subscore (r=0.39 p=0.065), PANSS hallucinations 
subscore (r=0.39 p=0.66) and PANSS thought disorder (r=0.41 p=0.051). They found 
no significant correlations between power or phase-locking factor and Scale for the 
Assessment of Positive Symptoms or Scale for the Assessment of Negative 
Symptoms. 
 
Williams, Whitford et al. (2009a) reported a negative correlation between change in 
PANSS reality distortion factor and left temporal synchrony (r=-0.621 p=0.006), 
indicating that an improvement in these symptoms was correlated with increased 
synchrony in this area. Spencer, Salisbury et al. (2008) reported a positive 
correlation between phase locking and PANSS positive scores (=0.72 p=0.003) in 
patients with first episode schizophrenia but did not find correlations in patients with 
first episode affective psychosis. Tada, Nagai et al. (2014) reported negative 
correlations between PANSS General scores and both inter trial coherence (r=-0.73 
p=0.004), and event related spectral perturbation (r=-0.70 p=0.008) in patients with 
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first episode schizophrenia. They also reported negative correlation of event related 
spectral perturbation with both PANSS positive scores (r=-0.53 p=0.04) and PANSS 
general psychopathology scores (r=-0.70 p=0.004) in people at CHR. Garakh, 
Zaytseva et al. (2015) reported negative correlation of PANNS positive score and 
power at Fp1 (r=-0.368), in patients with a first episode of schizoaffective disorder. 
 
Leicht, Andreou et al. (2015) reported a negative correlation between PANSS 
negative scores and both phase locking factor (=-0.510 p=0.05) and evoked power 
(=-0.600 p=0.02) in patients with first episode schizophrenia. They also reported a 
trend for correlation between evoked power and the disorganised factor of PANSS 
(=0.504 p=0.06). Williams, Whitford et al. (2009b) reported positive correlation of 
absolute synchrony at left temporal region and PANSS negative scores (R2=0.18) in 
patients with first episode schizophrenia. 
 
A number of studies found no correlation between symptoms scores and measures 
of gamma oscillations in patients with first episode psychosis (Gallinat, Winterer et al. 
2004, Flynn, Alexander et al. 2008, Kikuchi, Hashimoto et al. 2011) and those at 
CHR (Perez, Roach et al. 2013, Leicht, Vauth et al. 2016). 
 
3.6 Relationship with Cognition 
Tada, Nagai et al. (2014) reported that attentional functioning, measured by the Brief 
Assessment of Cognition in Schizophrenia, was significantly correlated with both 
inter trial coherence (r=0.75 p=0.003) and event related spectral perturbation (r=0.76 
p=0.003) in patients with first episode schizophrenia. Ramyead, Kometer et al. 
(2015) reported current source density of gamma oscillations was highly correlated 
with a scale for measuring abstract reasoning (r=0.734 p<0.001) in people at CHR 
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who went on to transition to psychosis, but not in those at CHR who did not transition 
or in healthy controls. 
 
Taylor, McCarley et al. (2013) reported no significant correlations between evoked 
power or phase locking factor and semantic or working memory measures in patients 
with first episode schizophrenia. Leicht, Vauth et al. (2016) report no correlation 
between error rates or reaction time in a cognitively demanding auditory task and 
gamma band responses. 
 
3.7 Bias 
The assessment of bias in each study is reported in Table 5 and the assessment of 
gamma artefacts in Table 6. 
 
4. Discussion 
In this systematic review, we identified 45 studies that examined gamma oscillations 
using EEG in the early phase of psychosis. The large degree of between-study 
heterogeneity in the participant population studied, in the stimuli used to evoke or 
induce gamma responses, and in the method employed to quantify the gamma signal 
precluded a meta-analysis. Overall, most studies of CHR subjects, familial risk 
subjects and first episode patients showed decreased evoked and induced power 
compared with healthy controls. A number of studies also reported increased resting 
gamma power in these groups, though this was a less consistent finding. 
 
4.1 First Episode Psychosis 
The largest group studied comprised patients with first episode psychosis. 
Decreased gamma power in response to a task was a relatively consistent finding, 
with 5 out of 6 studies reported reduced evoked or induced power. The only study 
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which did not find a difference in evoked power overall, reported decreased power in 
the right frontal region (Gallinat, Winterer et al. 2004). This is consistent with the 
patterns of deficits in gamma band responses found in chronic schizophrenia 
(Senkowski and Gallinat 2015). Mouse models suggest that hypofunction of the 
NMDA receptor on fast spiking parvalbumin positive interneurons underlies this 
impairment in gamma rhythm induction (Carlen, Meletis et al. 2012).  
 
Spontaneous gamma power was increased in one first episode study, but showed no 
statistically significant difference in 3 others. This is not in line with the suggestion 
that schizophrenia is associated with increased resting gamma power (White and 
Siegel 2016). It is also inconsistent with preclinical and computer models of NMDA 
receptor hypofunction, which predict increased baseline gamma power and 
decreased power in response to stimulus (Jadi, Behrens et al. 2016). These 
discrepancies relate to spontaneous gamma power being selectively increased 
during auditory steady state stimulation but not at rest, as has been reported in 
schizophrenia (Hirano, Oribe et al. 2015). 
 
The disconnection hypothesis (Friston, Brown et al. 2016) proposes that 
schizophrenia is associated with decreased markers of connectivity, such as 
coherence. Several studies reported that phase locking and phase synchrony in 
response to tasks were decreased, but others reported increases in omega 
complexity, global field synchronisation, and orthogonalised power envelope 
correlation. Measures of functional connectivity, such as coherence or phase 
synchronisation are particularly difficult to compare between studies, as there is no 
single optimal method. There are at least 42 different methods that can be used to 
measure oscillatory interactions, which can produce differing results from the same 
dataset (Wang, Benar et al. 2014). These must be interpreted cautiously, as issues 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 19 
such as common inputs, common references, differences in signal-to-noise ratio 
between channels and volume conduction can all lead to spurious results (Bastos 
and Schoffelen 2015). Notably, Andreou, Nolte et al. (2015) reported increased 
gamma band connectivity in first episode schizophrenia measured by orthogonalised 
power envelope correlation but in an overlapping sample, there was no difference in 
connectivity as measured by the multivariate interaction measure (Andreou, Leicht et 
al. 2015). The findings from studies that used EEG to assess functional connectivity 
in the early phase of psychosis were thus inconclusive. 
 
4.2 High Risk Subjects 
The decrease in both evoked and induced power that was evident in several first 
episode studies was also found in studies of CHR populations; all 3 studies 
measuring these features showed reductions compared with healthy controls. There 
was also a suggestion of increased resting gamma power, though this was a solitary 
report (Ramyead, Kometer et al. 2015). A measure of neural synchrony in the form of 
inter-trial phase coherence was decreased in CHR subjects (Tada, Nagai et al. 
2014), a finding that was also reported in first episode patients.  
 
The familial risk group showed results which were broadly in keeping with those in 
patients with first episode psychosis. Resting power was either increased or showed 
no difference between groups, evoked and induced gamma power was reduced in 3 
of 4 reports, and phase-locking factor was decreased in all 3 of the studies that 
reported this measure. As these gamma band abnormalities were present in the 
unaffected relatives of patients, it suggests they reflect a genetic susceptibility, and 
thus may represent trait biomarkers of psychosis (Koychev, Barkus et al. 2011). 
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It was more difficult to interpret the findings from studies of gamma oscillations in 
people with schizotypy, as they used a variety of different experimental designs, 
including correlation with schizotypy scores, comparisons between low and high 
schizotypy individuals, and comparison between schizotypal personality disorders 
and healthy controls. Furthermore, the results were largely inconsistent across 
studies.  
 
EEG abnormalities are of particular interest in subjects at CHR for psychosis, as they 
might be useful in facilitating the prediction of illness onset in a clinical setting. Most 
studies of CHR subjects to date have involved sample sizes that were too small to 
permit analysis of the relationship between gamma band measures and later 
transition to psychosis. Ramyead, Studerus et al. (2015), however, utilised a 
machine learning approach which incorporated measures of both beta and gamma 
oscillations from a sample of n=53 to predict which subjects would go on to develop 
psychosis. They predicted transition to psychosis with an AUC of 0.77. Perez, Roach 
et al. (2013) did not find differences between CHR subjects who subsequently 
transitioned and those who did not, in terms of evoked power, total power or phase-
locking factor. A key caveat in the interpretation of these findings is that the number 
of CHR subjects who subsequently developed psychosis in these studies was still 
small (n=18 and n=15, respectively), so they may have lacked the statistical power to 
detect significant effects. 
 
Correlations between measures of gamma oscillations and psychotic 
symptomatology were inconsistent between studies, with both positive and negative 
correlations, as well as no correlation reported. This is similar to the findings in 
patients with established schizophrenia, where both positive (Spencer, Niznikiewicz 
et al. 2009, Suazo, Diez et al. 2012, Hirano, Oribe et al. 2015), negative (Krishnan, 
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Vohs et al. 2005, Grutzner, Wibral et al. 2013, Spironelli and Angrilli 2015) as well as 
no correlations (Hamm, Ethridge et al. 2012, Roach, Ford et al. 2013, Tikka, Yadav 
et al. 2014) have been reported. This apparent discrepancy between studies may be 
partly explained by the use of differing experimental paradigms and differing aspects 
of gamma oscillations being measured.  
 
Two studies reported significant correlations of gamma oscillations and cognitive 
scores: using attentional functioning in first episode schizophrenia, and abstract 
reasoning in those at CHR who went on to develop psychosis. However, another two 
found no significant correlations. This contrasts with studies which report abnormal 
gamma oscillations are associated with poor performance in a number of cognitive 
tasks in patients with established schizophrenia (Senkowski and Gallinat 2015). 
Gamma oscillations are also proposed as a key mechanism for working memory in 
healthy subjects, particularly when coupled with theta oscillations (Lisman and 
Jensen 2013, Roux and Uhlhaas 2014). Lack of agreement between studies may be 
attributable to an inconsistency in the measures of cognitive function and in methods 
of examining gamma oscillations. 
 
4.3 Bias 
We assessed each study’s risk of bias using an adapted version of the Newcastle-
Ottawa scale. However, there are likely more forms of bias which are not detected by 
this scale. EEG is clearly a versatile investigational technique, whereby multiple 
measures and analyses can be undertaken in across a range of frequencies. It is 
conceivable that researchers may carry out multiple tasks and analyses yet only 
report those which are most favourable. Selective reporting of these outcomes would 
make a study prone to bias, with more statistically significant outcomes and analyses 
likely to be included (Ioannidis, Munafo et al. 2014). Unless a study protocol is made 
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available before the study commences, it is difficult to evaluate whether selective 
reporting has taken place. We did not find evidence for pre-specified outcomes and 
analyses in any of the included studies. There is suggestion of selective reporting by 
Donkers, Schwikert et al. (2011) who state in their methods that phase locking factor, 
evoked power and total power were compared between relatives and controls in the 
gamma band but do not report the results of these comparisons. Similarly, EEG uses 
a number of electrodes on which statistical inferences can be made. Some of the 
included studies used groups of electrodes in their analyses (Tikka, Yadav et al. 
2014), while others reported results for individual electrodes (Diez, Suazo et al. 
2014). Not only does this introduce more variability in the reporting of results, it also 
poses a multiple comparison problem, which no study seemed to account for in their 
reporting of statistics. The reproducibility of this field could be improved by 
investigators publishing protocols and analysis plans before conducting research, as 
well as incentivising replication of previously reported results (Ioannidis, Greenland et 
al. 2014). 
 
Within the literature examined, there was considerable variability in the way that the 
definitions of ‘first episode’ of a psychotic disorder were defined, ranging from 
presentation with psychotic symptoms for the first time, first hospitalisation for 
psychosis, or psychotic symptoms presenting for the first time in the past 24 months, 
or no clear definition at all. Most studies contained participants had been exposed to 
antipsychotic medication, which have been shown to affect gamma band oscillations 
(Alegre, Molero et al. 2017). 
 
Multiple artefacts can occur within the gamma band, potentially producing spurious 
results (Nottage and Horder 2015). Power line noise occurs at the frequency of 50 
Hz in Europe, which is within the gamma range. It is common to remove a frequency 
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band containing power line noise, for example with a notch filter. However, this could 
also remove neuronal gamma signal if it occurs at the same frequency and it may 
produce spurious oscillations in adjacent frequency bands (Nottage and Horder 
2015). Instead, power line noise should be removed by noise cancellation (Nottage, 
Morrison et al. 2013) or negated by using an electrically shielded room. Electrical 
activity of extra-ocular muscles associated with blinking is conventionally removed 
using regression weights calculated from average blink potentials, which are below 
the gamma frequency (Semlitsch, Anderer et al. 1986). In contrast, orbicularis oculi 
contraction during blinks occur within the gamma band and as yet, there are no 
published methods for removing this artefact (Nottage and Horder 2015). Therefore, 
it can only be reduced by keeping eyes closed or by excluding anterior electrodes 
from analysis. It has been demonstrated that saccadic eye muscle contraction 
accounts for previously published induced broad band gamma response 200-300ms 
after visual stimulus presentation (Yuval-Greenberg and Deouell 2009). This is 
particularly relevant as people at risk of psychosis have been shown to have 
increased saccadic eye movements (Gschwandtner, Aston et al. 2003, van Tricht, 
Nieman et al. 2010). Saccadic muscle potentials can be removed by recording 
electrical activity at the corner of each eye and subtracting a weighted average of 
these potentials from the EEG signal (Nottage 2010). A study of muscle paralysis 
suggests a major component of the gamma signal in published research is actually 
due to muscle activity of the face, scalp and neck (Whitham, Pope et al. 2007). 
Prolonged contraction of these muscles may particularly occur at times of stress or 
emotional arousal (Nottage and Horder 2015). In order to address scalp and neck 
muscle artefact, EMG should be recorded and removed, through mathematical 
modelling (Nottage, Morrison et al. 2013). An alternative way of addressing EMG 
contamination is through independent component analysis (Uriguen and Garcia-
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Zapirain 2015), but this method risks rejecting a proportion of genuinely neuronal 
gamma signal, as well as the artefact (Nottage and Horder 2015). 
 
Of the 45 studies included, only 6 adequately addressed our pre-specified sources of 
gamma band artefact (Table 7). Even amongst these, independent component 
analysis was used to remove artefact associated with ocular and facial electrical 
activity. This method is open to criticism (Nottage and Horder 2015) when correcting 
for saccades and electromyography. 25 studies did not address any of the potential 
sources of gamma artefact. A failure to adequately address the multiple non-
neuronal artefacts within the gamma range may have resulted in the discrepancy 
between studies included in this review. 
 
4.4 Sample Size 
The sample sizes in most of the studies were small which may have contributed to 
the inconsistency between studies. The mean sample size was 29 for first episode 
patients, 38 for CHR subjects, 46 for those at familial risk and 32 for studies of 
schizotypy. Sample size is a particular issue in studies which seek to link EEG 
abnormalities in high risk subjects to the subsequent onset of psychosis. Multi-centre 
studies provide a means of recruiting larger samples, and a number of these are 
currently ongoing (Addington, Cadenhead et al. 2012). However, the involvement of 
multiple centres can also introduce site effects, which must be controlled for in the 
analysis. Travelling subjects undergoing EEG recordings between sites, as well as 
standardisation of recruitment, presentation of stimuli, and acquisition of data may 
reduce this variation. 
 
4.5 Further Research Required 
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This systematic review suggests that gamma oscillations are altered in first episode 
psychosis and high risk groups, with most evidence for decreased evoked and 
induced power. However, there were also many inconsistent findings. Although most 
studies involved auditory stimuli, it is unclear whether this sensory modality is optimal 
for detecting gamma band abnormalities; visually stimulated gamma responses have 
also been shown to be abnormal in schizophrenia (Tan, Lana et al. 2013). A further 
caveat is that the literature to date is almost entirely comprised of cross-sectional 
studies. Longitudinal studies are required to determine whether gamma 
abnormalities are a trait or state biomarker of psychosis, whether they pre-date 
illness onset and whether they can be used clinically to predict outcome.  
 
It would be useful to integrate gamma band findings in the early phase of psychosis 
with findings from other neuroimaging techniques. However, few EEG studies to date 
have also collected data from other imaging modalities (Williams, Whitford et al. 
2009a, Leicht, Vauth et al. 2016). Since gamma oscillations are thought to be 
dependent on GABAergic interneurons, combining EEG with imaging techniques that 
can examine GABA function (such as MRS or PET) would be of particular interest. 
There is evidence from work in healthy volunteers that visually induced gamma 
oscillations measured by MEG are related to GABA-A receptor density, measured by 
the PET tracer flumazenil (Kujala, Jung et al. 2015). However, earlier reports that 
GABA concentration in the visual cortex measured by MRS predicts peak gamma 
frequency (Muthukumaraswamy, Edden et al. 2009) were not subsequently 
replicated (Cousijn, Haegens et al. 2014). The use of EEG in combination with other 
investigational techniques is of particular interest in the prediction of psychosis in 
subjects who are at high risk, in whom sequential testing using EEG, MRI and blood 
biomarkers may substantially improve prognostic accuracy in models in CHR 
populations (Schmidt, Cappucciati et al. 2017). However, the role of gamma 
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oscillations as a biomarker for outcomes in psychosis needs further clarification 
before its clinical utility can be realised 
 
4.6 Limitations 
At present, the literature in this area comprises studies that are heterogeneous with 
respect to the clinical samples, the tasks used to elicit gamma oscillations, the 
methods used to quantify features of gamma oscillations, the methods used to 
quantify features of gamma oscillations, and the steps taken to reduce artefacts. This 
precluded a meta-analysis of the findings, limiting our study to a systematic review. 
Although we quantified risk of bias using an established tool, there may still have 
been reporting biases that were less explicit. The amount of data reported by each 
study was also variable. We calculated effect sizes when the necessary data were 
available but this was not possible for studies that did not report means, standard 
deviations, or relevant test statistics. Some studies reported results for each 
individual EEG electrode used (for example, Diez, Suazo et al. (2013)). Rather than 
listing each electrode, we chose to report data from the electrodes with the greatest 
signal, as this was the convention used by most of the other studies that we included. 
 
5. Conclusion 
Although at present the literature is too small and heterogeneous to permit a meta-
analysis, a systematic review of EEG studies in people at high risk for psychosis and 
patients with first episode psychosis indicates that decreased evoked and induced 
gamma band responses are evident in both groups. There is also some evidence 
that both groups show increased spontaneous power at rest. These findings suggest 
that EEG measures in the early phase of psychosis have the potential to be used as 
biomarkers. Studies using larger samples, serial measurements, and designs that 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 27 
minimise the artefacts that occur at the gamma band frequency may advance work in 
this area.  
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Appendix  
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
CASE CONTROL STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection 
and Exposure categories. A maximum of two stars can be given for Comparability. 
 
Selection 
1) Is the case definition (diagnosis) adequate? 
a) yes, with validated diagnostic instrument (e.g. DSM, ICD, CAARMS, SIPS) ✵ 
b) yes, e.g. record linkage or clinical diagnosis 
c) no description 
2) Representativeness of the cases 
a) consecutive or obviously representative series of cases ✵ 
b) potential for selection biases or not stated 
3) Selection of Controls 
a) community controls (same community as cases) ✵ 
b) hospital controls or potential for selection bias 
c) no description 
4) Definition of Controls 
a) no history of diagnosis of psychotic disorder, for controls of familial risk, no family history of 
psychotic disorder ✵ 
b) no description  
Comparability 
1) Comparability of cases and controls on the basis of the design or analysis 
a) study controls for sex and age ✵ 
b) study controls for any additional factor ✵   
 
Exposure 
1) Ascertainment of gamma 
a) secure record (e.g. surgical records) Not applicable  
b) neurophysiological analysis where blind to case/control status ✵ 
c) neurophysiological analysis not blinded to case/control status 
d) written self-report or medical record only Not applicable 
e) no description 
2) Same method of ascertainment for cases and controls 
a) yes ✵ 
b) no 
3) Missing data rate 
a) same rate for both groups ✵ 
b) non-respondents described 
c) rate different and no designation 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 38 
Figure Captions 
 
↓GAD
NMDA 
receptor 
hypofunction
GABA-A 
Receptor
Fast spiking PV+ 
interneuron
Pyramidal 
neuronal 
assemblies
EEG in people with 
psychosis
Gamma oscillations
Animal models of psychosis
Figure 1 
Diagrammatic representation of the production of gamma oscillations. Activation of 
pyramidal neuronal assemblies, is synchronised by fast-spiking parvalbumin positive 
GABAergic interneurons. This may be dysfunctional in psychosis through NMDA receptor 
hypofunction and decreased glutamic acid decarboxylase (GAD). As gamma oscillations are 
well preserved across species, they can be examined using animal models. They can also be 
measured directly through EEG. 
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Database Search
n=1647
Additional records 
from other sources
n=12
After duplicates 
removed
n=1039
Full text articles 
retrieved 
n=139
Articles included
n=45
Duplicates
n=620
Excluded on 
title/abstract
n=794
Excluded on 
full text
n=104
 
Figure 2 
PRISMA flow diagram of included studies.  
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Tables  
 
Table 1. Measures of Gamma Oscillations Included in this review 
Measure Description 
Resting Power Power is defined as amplitude of the waveform squared. Resting EEG may be recorded 
with eyes opened or closed. 
Evoked Power Change in power which is time-locked and phase-locked to a stimulus. 
Induced Power Change in power which is time-locked to a stimulus but not phase-locked. Also called 
event related spectral perturbation. 
Total Power Change in power which contains both phase-locked and non-phase-locked power. 
Noise Power Power not time-locked to stimulus, calculated as the difference between the mean 
power of single trials and the power magnitude in the averaged potential. Also known as 
noise magnitude. 
Peak Frequency The frequency with the highest magnitude within the gamma range, measured in Hz. 
Global Field 
Synchronisation 
Estimates the relative phase synchrony over all electrodes at a given frequency, 
calculated by the fraction of total power across electrodes that can be explained by a 
single phase. 
Coherence Consistency of signal between two channels (various measures of consistency may be 
used, for example spectral power). 
Mean Phase 
Difference 
Difference in the mean angle of the sinusoidal waveform between two channels. 
Orthogonalised 
Power Envelope 
Correlation 
Same-phase signal components are removed (to avoid spurious correlations from the 
same source) before power estimates and their correlation are calculated. 
Omega 
Complexity 
Measure of the global complexity of multi-channel EEG data across the entire scalp, 
calculated using spatial principal components analysis for all channels. 
Inter-Trial Phase 
Coherence 
Degree of phase synchronisation across trials between EEG data and time-locking 
events. Also called inter-trial phase locking and phase-locking factor. 
Phase 
Synchrony 
A singular estimate of the degree of phase-locking across multiple electrodes. Defined as 
the inverse of circular variance, which is computed from the phase estimate of each 
electrode, independent from the amplitude.  
Current Source 
Density 
A reference-independent measure of the direction, location and intensity of current 
generators underlying the grossly recorded EEG. Defined as the second spatial derivative 
of local field potentials. 
Multivariate 
Interaction 
Measure 
 Measures the interaction between vector signals based on complex coherence. 
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Table 2. Gamma Oscillations in First Episode Psychosis 
Study Diagnosis Diagnostic Tool Definition of first 
episode 
Patient 
Number 
Control 
Number Task 
Measurement 
of Gamma 
Oscillations 
Summary of findings 
Direction of 
difference, 
compared 
with controls 
Hedge’s 
g 
Andreou, 
Nolte et al. 
(2015) 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and psychiatric 
treatment in the 
past year and 
presence of 
psychotic 
symptoms in any 
form for no more 
than five years, 18 
receiving 
antipsychotics.  
22 22 
Resting, 
eyes 
closed 
Orthogonalised 
power envelope 
correlation 
Increased mean functional gamma-
band connectivity in the left rolandic 
operculum of patients compared to 
controls 
↑  N/A 
Andreou, 
Nolte et al. 
(2015) 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and psychiatric 
treatment in the 
past year and 
presence of 
psychotic 
symptoms in any 
form for no more 
than five years, 18 
receiving 
antipsychotics 
22 22 
Resting, 
eyes 
closed 
Spontaneous 
power 
No difference in gamma power 
compared with healthy controls  -0.038 
Garakh, 
Zaytseva et 
al. (2015) 
Schizophrenia 
(n=32), 
Schizoaffective 
disorder (n=32) 
ICD-10 
First episode in 
the 
acute/subacute 
phase, recruited 
on admission to 
Early Intervention 
clinic, receiving 
antipsychotics 
64 40 
Resting, 
eyes 
closed and 
an 
arithmetic 
task 
Spectral power 
at midline, 
anterior, central 
and posterior 
No statistical difference between first 
episode schizophrenia, first episode 
schizoaffective disorder or healthy 
controls, however mean power for 
each group not reported 
 N/A 
Kikuchi, 
Hashimoto 
et al. (2011) 
Schizophrenia DSM-IV Drug naïve 21 21 
Resting, 
eyes 
closed 
Omega 
complexity 
Increased gamma band omega 
complexity compared with healthy 
controls 
↑  0.639 
Kikuchi, 
Koenig et al. 
(2007) 
Schizophrenia DSM-IV Drug naïve 21 21 
Resting, 
eyes 
closed 
Global field 
synchronisation 
(within gamma 
band (30.5-40.2 
Hz)) 
Increased mean gamma global field 
synchronisation compared with 
healthy controls 
↑  1.455 
Ramyead, 
Studerus et 
al. (2016) 
Schizophrenia 
(n=17), 
Schizoaffective 
disorder (n=2), 
Acute 
polymorphic 
psychotic disorder 
(n=7), Schizotypal 
disorder (n=1) 
ICD-10 
Drug naïve, 
transition to 
psychosis defined 
by CAARMS 
criteria 
31 29 
Resting, 
eyes 
closed 
Current source 
density 
(μA/mm2) 
Increased activity in the left medial 
frontal gyrus 
↑  N/A 
Tikka, 
Yadav et al. 
(2014) 
Schizophrenia ICD-10 DRC 
Drug naïve, first 
episode not 
defined 
37 30 
Resting, 
eyes 
closed 
Spectral power, 
left frontal, low 
gamma (30-50 
Hz) 
Increased spectral power compared 
with healthy controls ↑  0.602 
Tikka, 
Yadav et al. 
(2014) 
Schizophrenia ICD-10 DRC 
Drug naïve, first 
episode not 
defined 
37 30 
Resting, 
eyes 
closed 
Spectral power, 
left parietal, low 
gamma (30-50 
Hz) 
Increased spectral power compared 
with healthy controls ↑  0.480 
Yeragani, 
Cashmere 
et al. (2006) 
Schizophrenia 
(n=8), 
schizoaffective 
disorder (n=2) 
Structured Clinical 
Interview for 
DSM-IV 
Drug naïve, first 
episode not 
defined 
8 8 Resting 
Spontaneous 
spectral power 
of C4 
Decreased spectral power compared 
with healthy controls (non-significant) ↓ -0.483 
Yeragani, 
Cashmere 
et al. (2006) 
Schizophrenia 
(n=8), 
schizoaffective 
disorder (n=2) 
Structured Clinical 
Interview for 
DSM-IV 
Drug naïve, first 
episode not 
defined 
8 8 Resting 
Spontaneous 
spectral power 
of F4 
Decreased spectral power compared 
with healthy controls (non-significant) ↓ -0.506 
Yeragani, 
Cashmere 
et al. (2006) 
Schizophrenia 
(n=8), 
schizoaffective 
disorder (n=2) 
Structured Clinical 
Interview for 
DSM-IV 
Drug naïve, first 
episode not 
defined 
8 8 Resting 
Mean 
coherence 
between C4 and 
F4 
Decreased coherence compared with 
healthy controls ↓ -1.430 
Yeragani, 
Cashmere 
et al. (2006) 
Schizophrenia 
(n=8), 
schizoaffective 
disorder (n=2) 
Structured Clinical 
Interview for 
DSM-IV 
Drug naïve, first 
episode not 
defined 
8 8 Resting 
Mean phase 
(degrees) 
between C4 and 
F4 
Decreased coherence compared with 
healthy controls (non-significant) ↓ -0.126 AC
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Study Diagnosis Diagnostic Tool Definition of first 
episode 
Patient 
Number 
Control 
Number Task 
Measurement 
of Gamma 
Oscillations 
Summary of findings 
Direction of 
difference, 
compared 
with controls 
Hedge’s 
g 
Flynn, 
Alexander 
et al. (2008) 
Schizophrenia 
(n=32), 
schizophreniform 
disorder (12), 
psychosis not 
otherwise 
specified (n=4), 
schizoaffective 
bipolar type (n=2), 
schizoaffective 
depressive type 
(n=1), bipolar, 
manic (n=1), 
bipolar depressive 
(n=1), major 
depression with 
psychotic features 
(n=1), substance 
induced 
psychosis (n=1) 
Structured Clinical 
Interview for 
DSM-IV 
First contact with a 
mental health 
service, 50 
receiving 
antipsychotics 
55 110 Auditory 
oddball 
Phase 
synchrony 
Increased gamma phase synchrony 
compared with healthy controls ↑  N/A 
Gallinat, 
Winterer et 
al. (2004) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
10 patients drug 
naive first episode, 
5 were medication 
free for four weeks  
15 15 Auditory 
oddball 
Early evoked 
response (20-
100ms) 
No difference in evoked gamma 
response compared with healthy 
controls. 
 N/A 
Gallinat, 
Winterer et 
al. (2004) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
10 patients drug 
naive first episode, 
5 were medication 
free for four weeks  
15 15 Auditory 
oddball 
Late evoked 
response (220-
350ms) 
No difference in evoked gamma 
response compared with healthy 
controls overall, decreased evoked 
gamma response in patients over 
right frontal region only. 
 N/A 
Slewa-
Younan, 
Gordon et 
al. (2004) 
 
Schizophrenia 
Composite 
International 
Diagnostic 
Interview 
First presentation 
to health services 
with psychotic 
symptoms, 
receiving 
antipsychotics 
24 24 Auditory 
oddball 
Early gamma 
phase 
synchrony 
(circular 
variance) 
Decreased gamma phase synchrony 
compared with healthy controls ↓ N/A 
Slewa-
Younan, 
Gordon et 
al. (2004) 
 
Schizophrenia 
Composite 
International 
Diagnostic 
Interview 
First presentation 
to health services 
with psychotic 
symptoms, 
receiving 
antipsychotics 
24 24 Auditory 
oddball 
Magnitude of 
early phase 
gamma 
synchrony 
Decreased gamma magnitude in left 
and right hemispheres compared with 
healthy controls 
↓ N/A 
Slewa-
Younan, 
Gordon et 
al. (2004) 
 
Schizophrenia 
Composite 
International 
Diagnostic 
Interview 
First presentation 
to health services 
with psychotic 
symptoms, 
receiving 
antipsychotics 
24 24 Auditory 
oddball 
Latency of early 
gamma phase 
synchrony 
(msec) 
Increased latency of frontal 
synchrony relative to posterior 
synchrony compared with healthy 
controls 
↑  N/A 
Symond, 
Harris et al. 
(2005) 
Schizophrenia 
Semistructured 
interview, based 
on ICD-10 and 
DSM-IV criteria 
First episode not 
defined, 36 
receiving 
antipsychotic 
medication 
40 40 Auditory 
oddball 
Global 
synchrony - 
magnitude 
(standarized 
circular variance 
index) (early 
gamma) 
Lower magnitude of global early 
gamma compared with healthy 
controls 
↓ -0.875 
Symond, 
Harris et al. 
(2005) 
Schizophrenia 
Semistructured 
interview, based 
on ICD-10 and 
DSM-IV criteria 
First episode not 
defined, 36 
receiving 
antipsychotic 
medication 
40 40 Auditory 
oddball 
Global 
synchrony - 
magnitude 
(standarized 
circular variance 
index) (late 
gamma) 
Lower magnitude of global late 
gamma compared with healthy 
controls (non-significant) 
↓ -0.140 
Symond, 
Harris et al. 
(2005) 
Schizophrenia 
Semistructured 
interview, based 
on ICD-10 and 
DSM-IV criteria 
First episode not 
defined, 36 
receiving 
antipsychotic 
medication 
40 40 Auditory 
oddball 
Global 
synchrony - 
Latency (msec) 
(early gamma) 
Increased latency of global early 
gamma compared with healthy 
controls 
↑  0.408 
Symond, 
Harris et al. 
(2005) 
Schizophrenia 
Semistructured 
interview, based 
on ICD-10 and 
DSM-IV criteria 
First episode not 
defined, 36 
receiving 
antipsychotic 
medication 
40 40 Auditory 
oddball 
Global 
synchrony - 
Latency (msec) 
(late gamma) 
Increased latency of global late 
gamma compared with healthy 
controls (non-significant) 
↑  0.174 
Taylor, 
McCarley et 
al. (2013) 
Schizophrenia 
(n=18), 
schizoaffective 
(n=8), 
schizophreniform 
(n=1), delusional 
disorder (n=1) 
Structured Clinical 
Interview for 
DSM-IV 
Within a year of 
first 
hospitalisation, 
receiving 
antipsychotics  
28 44 Auditory 
oddball 
Evoked power 
(at Fz) 
Decreased evoked gamma power 
compared with healthy controls ↓ -0.493 
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Study Diagnosis Diagnostic Tool Definition of first 
episode 
Patient 
Number 
Control 
Number Task 
Measurement 
of Gamma 
Oscillations 
Summary of findings 
Direction of 
difference, 
compared 
with controls 
Hedge’s 
g 
Taylor, 
McCarley et 
al. (2013) 
Schizophrenia 
(n=18), 
schizoaffective 
(n=8), 
schizophreniform 
(n=1), delusional 
disorder (n=1) 
Structured Clinical 
Interview for 
DSM-IV 
Within a year of 
first 
hospitalisation, 
receiving 
antipsychotics  
28 44 Auditory 
oddball 
Evoked Power 
(at Cz) 
Decreased evoked gamma power 
compared with healthy controls ↓ -0.450 
Taylor, 
McCarley et 
al. (2013) 
Schizophrenia 
(n=18), 
schizoaffective 
(n=8), 
schizophreniform 
(n=1), delusional 
disorder (n=1) 
Structured Clinical 
Interview for 
DSM-IV 
Within a year of 
first 
hospitalisation, 
receiving 
antipsychotics  
28 44 Auditory 
oddball 
Intertrial phase 
locking (at Fz) 
Decreased intertrial phase locking 
compared with healthy controls ↓ -0.603 
Taylor, 
McCarley et 
al. (2013) 
Schizophrenia 
(n=18), 
schizoaffective 
(n=8), 
schizophreniform 
(n=1), delusional 
disorder (n=1) 
Structured Clinical 
Interview for 
DSM-IV 
Within a year of 
first 
hospitalisation, 
receiving 
antipsychotics  
28 44 Auditory 
oddball 
Intertrial phase 
locking (at Cz) 
Decreased intertrial phase locking 
compared with healthy controls ↓ -0.429 
Williams, 
Whitford et 
al. (2009a) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
Within 3 months of 
presentation to 
mental health 
services, receiving 
antipsychotics 
25 23 Auditory 
oddball 
Early gamma 
synchrony 
(circular 
variance) 
Decreased early gamma synchrony 
compared with healthy controls ↓ -0.685 
Williams, 
Whitford et 
al. (2009a) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
Within 3 months of 
presentation to 
mental health 
services, receiving 
antipsychotics 
25 23 Auditory 
oddball 
Late gamma 
synchrony 
(circular 
variance) 
Decreased late gamma synchrony 
compared with healthy controls ↓ -0.604 
Spencer, 
Salisbury et 
al. (2008) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
First 
hospitalisation, 
receiving 
antipsychotics 
16 33 
Auditory 
steady 
state 
responses 
Evoked power 
(μV2) 
Decreased evoked gamma power 
compared with healthy controls ↓ N/A 
Spencer, 
Salisbury et 
al. (2008) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
First 
hospitalisation, 
receiving 
antipsychotics 
16 33 
Auditory 
steady 
state 
responses 
Phase locking 
factor 
Decreased phase locking compared 
with healthy controls ↓ N/A 
Spencer, 
Salisbury et 
al. (2008) 
Bipolar affective 
disorder with 
psychotic 
symptoms (n=13), 
major depression 
with psychotic 
symptoms (n=3) 
Structured Clinical 
Interview for 
DSM-IV 
First 
hospitalisation, 
receiving 
antipsychotics 
16 33 
Auditory 
steady 
state 
responses 
Evoked power 
(μV2) 
Decreased evoked gamma power 
compared with healthy controls ↓ -0.598 
Spencer, 
Salisbury et 
al. (2008) 
Bipolar affective 
disorder with 
psychotic 
symptoms (n=13), 
major depression 
with psychotic 
symptoms (n=3) 
Structured Clinical 
Interview for 
DSM-IV 
First 
hospitalisation, 
receiving 
antipsychotics 
16 33 
Auditory 
steady 
state 
responses 
Phase locking 
factor 
Decreased phase locking compared 
with healthy controls ↓ -0.603 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
receiving 
antipsychotics 
13 21 
Auditory 
steady 
state 
responses 
Event related 
spectral 
perturbation at 
200-300ms 
Decreased event-related spectral 
perturbation compared with healthy 
controls 
↓ -1.039 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
receiving 
antipsychotics 
13 21 
Auditory 
steady 
state 
responses 
Event related 
spectral 
perturbation at 
300-400ms 
Decreased event-related spectral 
perturbation compared with healthy 
controls 
↓ -1.107 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
13 21 
Auditory 
steady 
state 
responses 
Event related 
spectral 
perturbation at 
400-500ms 
Decreased event-related spectral 
perturbation compared with healthy 
controls 
↓ -0.944 
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Study Diagnosis Diagnostic Tool Definition of first 
episode 
Patient 
Number 
Control 
Number Task 
Measurement 
of Gamma 
Oscillations 
Summary of findings 
Direction of 
difference, 
compared 
with controls 
Hedge’s 
g 
receiving 
antipsychotics 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
receiving 
antipsychotics 
13 21 
Auditory 
steady 
state 
responses 
Intertrial phase 
coherence at 
200-300ms 
Decreased intertrial phase coherence 
compared with healthy controls ↓ -0.783 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
receiving 
antipsychotics 
13 21 
Auditory 
steady 
state 
responses 
Intertrial phase 
coherence at 
300-400ms 
Decreased intertrial phase coherence 
compared with healthy controls ↓ -0.844 
Tada, Nagai 
et al. (2014) Schizophrenia DSM-IV 
Continuous 
psychotic 
symptoms within 
the past 24 
months, without 
previously 
demonstrating 
psychotic 
symptoms, 
receiving 
antipsychotics 
13 21 
Auditory 
steady 
state 
responses 
Intertrial phase 
coherence at 
400-500ms 
Decreased intertrial phase coherence 
compared with healthy controls ↓ -0.783 
Leicht, 
Andreou et 
al. (2015) 
 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and treatment less 
than a year prior 
to study 
participation, 19 
receiving 
antipsychotics 
21 21 
Auditory 
reaction 
task 
Evoked power 
(μV2) (easy 
condition) 
Decreased evoked gamma power 
compared with healthy controls (non-
significant) 
↓ -0.3 
Leicht, 
Andreou et 
al. (2015) 
 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and treatment less 
than a year prior 
to study 
participation, 19 
receiving 
antipsychotics 
21 21 
Auditory 
reaction 
task 
Evoked power 
(μV2) (difficult 
condition) 
Decreased evoked gamma power 
compared with healthy controls ↓ -0.666 
Leicht, 
Andreou et 
al. (2015) 
 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and treatment less 
than a year prior 
to study 
participation, 19 
receiving 
antipsychotics 
21 21 
Auditory 
reaction 
task 
Phase locking 
factor (easy 
condition) 
Decreased phase locking factor 
compared with healthy controls (non-
significant) 
↓ -0.261 
Leicht, 
Andreou et 
al. (2015) 
 
Schizophrenia 
Mini International 
Neuropsychiatric 
Interview 
First diagnosis 
and treatment less 
than a year prior 
to study 
participation, 19 
receiving 
antipsychotics 
21 21 
Auditory 
reaction 
task 
Phase locking 
factor (difficult 
condition) 
Decreased phase locking factor 
compared with healthy controls ↓ -0.654 
Minzenberg, 
Firl et al. 
(2010) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV TR or 
Kiddie-SADS-
Present and 
Lifetime Version, if 
under 18 years 
Onset of 
psychosis less 
than a year prior 
to study 
participation, 32 
receiving 
antipsychotics 
53 29 
Cognitive 
task - 
preparing 
to 
overcome 
prepotency 
Induced power 
(frontal) 
Decreased gamma power compared 
with healthy controls ↓ -0.782 
Williams, 
Whitford et 
al. (2009b) 
Schizophrenia 
Structured Clinical 
Interview for 
DSM-IV 
First contact with a 
mental health 
service with 
psychotic 
symptoms, 
recruited within 8 
months of 
presentation, 26 
receiving 
antipsychotics 
28 72 
Facial 
emotion 
perception 
Absolute 
gamma 
synchrony 
(inverse circular 
variance) at left 
temporal region 
Increased absolute gamma 
synchrony, compared with healthy 
controls.  
↑  0.75 
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Table 3. Gamma Oscillations in Clinical High Risk 
Study Definition of risk At Risk Number Control Number Task 
Measurement of 
gamma 
oscillations 
Summary of findings 
Direction of 
difference, 
compared with 
controls 
Hedge’s g 
Andreou, Leicht et 
al. (2015) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
28 23 Resting state, eyes 
closed Spontaneous power 
No difference in spectral 
power between groups  N/A 
Andreou, Leicht et 
al. (2015) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
28 23 Resting state, eyes 
closed Resting connectivity 
No difference in connectivity 
between groups  N/A 
Leicht, Vauth et al. 
(2016) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
27 26 
Auditory reaction 
task 
 
Latency of peak 
gamma band 
response (ms) 
No difference in gamma peak 
latency between groups  -0.014 
Leicht, Vauth et al. 
(2016) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
27 26 
Auditory reaction 
task 
 
Evoked spectral 
power (μV2) 
Decreased spectral power 
compared with healthy 
controls 
↓ -0.501 
Leicht, Vauth et al. 
(2016) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
27 26 
Auditory reaction 
task 
 
Phase locking factor 
Decreased phase locking 
factor compared with healthy 
controls (non-significant) 
↓ -0.398 
Leicht, Vauth et al. 
(2016) 
 
Early Detection and 
Intervention 
program of the 
German Research 
Network on 
Schizophrenia 
Criteria 
 
27 26 
Auditory reaction 
task 
 
Peak frequency 
(Hz) 
Decreased peak frequency 
compared with healthy 
controls 
↓ -0.149 
Perez, Roach et al. 
(2013) 
 
Criteria for 
Prodromal 
Syndrome 
43 42 Auditory oddball 
task 
Evoked spectral 
power 
Decreased evoked power 
compared with healthy 
controls  
↓ -0.559 
Perez, Roach et al. 
(2013) 
 
Criteria for 
Prodromal 
Syndrome 
43 42 Auditory oddball 
task Total power 
Decreased total power 
compared with healthy 
controls (non-significant) 
↓ -0.087 
Perez, Roach et al. 
(2013) 
 
Criteria for 
Prodromal 
Syndrome 
43 42 Auditory oddball 
task Phase locking factor 
Decreased phase locking 
factor compared with healthy 
controls (trend level 
significance) 
↓ -0.415 
Ramyead, Kometer 
et al. (2015) 
Basel Screening 
Instrument for 
Psychosis (based 
on PACE criteria). 
ARMS-T (n=23), 
ARMS-NT (n=40) 
63 29 Resting state, eyes 
closed 
Current source 
density (μA/mm2)  
 
Source frontal activity 
progressively increased from 
HC to ARMS-NT to ARMS-T. 
ARMS-T increased gamma 
activity in mPFC bilaterally 
↑  N/A 
Ramyead, Kometer 
et al. (2015) 
Basel Screening 
Instrument for 
Psychosis (based 
on PACE criteria). 
ARMS-T (n=23), 
ARMS-NT (n=40) 
63 29 Resting state, eyes 
closed 
Lagged phase 
synchronisation 
Stronger decreasing lagged 
phase synchronicity with 
increasing Euclidian distance 
in ARMS-T than ARMS-NT 
and healthy controls 
NR N/A 
Ramyead, Kometer 
et al. (2015) 
Basel Screening 
Instrument for 
Psychosis (based 
on PACE criteria). 
ARMS-T (n=23), 
ARMS-NT (n=40) 
63 29 Resting state, eyes 
closed 
Spontaneous 
spectral power (μV) 
ARMS-T showed increased 
gamma power in medial 
prefrontal cortex compared 
with healthy controls 
↑  N/A 
Ramyead, Studerus 
et al. (2015) 
Basel Screening 
Instrument for 
Psychosis (based 
on PACE criteria). 
ARMS-T (n=18), 
ARMS-NT (n=35) 
53 N/A Resting state, eyes 
closed 
Machine learning of 
current source 
density and lagged 
phase 
synchronisation 
across frequency 
bands 
Three highest gamma band 
contributors to prediction were 
the left inferior parietal lobule, 
precuneus and the right 
posterior temporal cortex 
NR N/A 
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Study Definition of risk At Risk Number Control Number Task 
Measurement of 
gamma 
oscillations 
Summary of findings 
Direction of 
difference, 
compared with 
controls 
Hedge’s g 
Tada, Nagai et al. 
(2014) 
Structured Interview 
for Prodromal 
Symptoms 
15 21 Auditory steady 
state response 
Intertrial phase 
coherence at 400-
500ms 
Decreased intertrial phase 
coherence compared with 
healthy controls 
↓ N/A 
Tada, Nagai et al. 
(2014) 
Structured Interview 
for Prodromal 
Symptoms 
15 21 Auditory steady 
state response 
Event related 
spectral 
perturbation 
Decreased event-related 
spectral perturbation 
compared with healthy 
controls 
↓ N/A 
Tada, Nagai et al. 
(2014) 
 
Structured Interview 
for Prodromal 
Symptoms 
15 21 Auditory steady 
state response 
Intertrial phase 
coherence at 300-
400ms 
Decreased intertrial phase 
coherence compared with 
healthy controls 
↓ N/A 
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Table 4. Gamma Oscillations in Familial High Risk 
Study Definition of risk At Risk 
Number 
Control 
Number Task 
Measurement of gamma 
oscillations Summary of findings 
Direction 
of 
difference 
Hedge’s g 
Bandyopadhyaya, 
Nizamie et al. 
(2011) 
First degree relatives 
of schizophrenia 
patients, with no 
psychiatric disorder 
20 20 Resting state Spontaneous power 
spectral density 
Increased left temporal 
spontaneous power in relatives 
compared with healthy controls 
↑  N/A 
Bandyopadhyaya, 
Nizamie et al. 
(2011) 
First degree relatives 
of schizophrenia 
patients, with no 
psychiatric disorder 
20 20 Resting state Coherence (Inter H Frontal) Decreased coherence in relatives 
compared with healthy controls ↓ -0.91 
Bandyopadhyaya, 
Nizamie et al. 
(2011) 
 
First degree relatives 
of schizophrenia 
patients, with no 
psychiatric disorder 
20 20 Resting state Coherence (Inter H 
Parietal) 
Decreased coherence in relatives 
compared with healthy controls ↓ -0.929 
Bandyopadhyaya, 
Nizamie et al. 
(2011) 
 
First degree relatives 
of schizophrenia 
patients, with no 
psychiatric disorder 
20 20 Resting state Coherence (Inter H 
Temporal) 
Decreased coherence in relatives 
compared with healthy controls ↓ -0.728 
Diez, Suazo et al. 
(2013) 
First degree relatives 
of schizophrenia with 
no Axis I psychiatric 
disorder and who had 
not received 
psychiatric treatment 
23 27 Auditory oddball 
task 
Noise power value at O1 
(µV2)  
No difference in gamma noise 
magnitude between first degree 
relatives and healthy controls. 
 N/A 
Diez, Suazo et al. 
(2014) 
First degree relatives 
of schizophrenia 
patients, with no 
psychiatric disorder 
24 27 Auditory oddball 
task 
Total spectral power at T5 
(μV2) 
No difference in gamma spectral 
power between relatives and 
controls. Inverse association of 
gamma power with verbal and 
working memory 
 -0.105 
Donkers, Schwikert 
et al. (2011) 
Adolescent first 
degree relatives of 
schizophrenia or 
schizoaffective 
disorder patients 
24 30 Visual oddball 
task 
Phase locking factor, 
evoked power and total 
power 
Methods state phase locking factor, 
evoked power or total power 
compared between relatives and 
controls in the gamma band. 
However, group means and 
statistical tests not reported for 
gamma - only delta, theta and 
alpha. 
NR N/A 
Hall, Taylor et al. 
(2011a) 
 
Monozygotic well co-
twins whose twin has 
a diagnosis of 
schizophrenia 
9 147 Auditory oddball 
task 
Evoked spectral power 
(μV2) 
Decreased spectral power of 
unaffected identical co-twins 
compared with controls 
↓ -0.520 
Hall, Taylor et al. 
(2011a) 
 
Monozygotic well co-
twins whose twin has 
a diagnosis of 
schizophrenia 
9 147 Auditory oddball 
task Phase locking factor 
Decreased phase locking factor of 
unaffected identical co-twins 
compared with controls (non-
significant) 
↓ -0.460 
Hall, Taylor et al. 
(2011b) 
Relatives of 
schizophrenia or 
schizoaffective 
disorder patients who 
did not have a lifetime 
diagnosis of psychotic 
disorder, bipolar 
disorder, or a 
schizophrenia 
spectrum personality 
disorder 
25 34 Paired auditory 
clicks 
Evoked spectral power to 
paired stimuli 
No statistical difference in evoked 
spectral power between relatives 
and healthy controls for either 
stimuli 1, stimuli 2, or the 
subtraction of these 
 N/A 
Hong, Summerfelt 
et al. (2004) 
First degree relatives 
with schizophrenia 
spectrum personality 
traits 
11 17 Auditory steady 
state response 
Evoked spectral power 
(μV2) 
Decreased spectral power in first 
degree relatives with schizophrenia 
spectrum personality symptoms 
compared with healthy controls 
↓ N/A 
Hong, Summerfelt 
et al. (2012) 
First degree relatives 
of schizophrenia 
patients, without 
schizophrenia 
80 110 Resting state, 
eyes closed 
Single trial spontaneous 
power spectrum density, 
low gamma (20-40 Hz) 
No difference in gamma power 
spectrum density between relatives 
and controls 
 N/A 
Hong, Summerfelt 
et al. (2012) 
First degree relatives 
of schizophrenia 
patients, without 
schizophrenia 
80 110 Resting state, 
eyes closed 
Single trial spontaneous 
power spectrum density, 
gamma (40-85 Hz) 
No difference in gamma power 
spectrum density between relatives 
and controls 
 -0.170 
Hong, Summerfelt 
et al. (2012) 
First degree relatives 
of schizophrenia 
patients, without 
schizophrenia 
80 110 Resting state, 
eyes closed 
Single trial spontaneous 
power spectrum density, 
high gamma (>85Hz) 
Not reported but similar results to 
(40-85Hz)  N/A 
Hong, Summerfelt 
et al. (2012) 
First degree relatives 
of schizophrenia 
patients, without 
schizophrenia 
80 110 Paired auditory 
clicks 
Single trial power spectrum 
density, low gamma (20-40 
Hz) 
No difference in gamma power 
spectrum density between relatives 
and controls 
 N/A 
Hong, Summerfelt 
et al. (2012) 
First degree relatives 
of schizophrenia 
patients, without 
schizophrenia 
80 110 Paired auditory 
clicks 
Single trial power spectrum 
density, gamma (40-85 Hz) 
No difference in gamma power 
spectrum density between any 
groups 
 N/A 
Leicht, Karch et al. 
(2011) 
Siblings of patients 
with schizophrenia, 
with no lifetime history 
of psychotic disorder  
17 17 
Auditory 
reaction task 
 
Phase locking factor 
Decreased phase locking factor of 
unaffected siblings compared with 
controls 
↓ -1.079 
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Study Definition of risk At Risk 
Number 
Control 
Number Task 
Measurement of gamma 
oscillations Summary of findings 
Direction 
of 
difference 
Hedge’s g 
Leicht, Karch et al. 
(2011) 
 
Siblings of patients 
with schizophrenia, 
with no lifetime history 
of psychotic disorder  
17 17 
Auditory 
reaction task 
 
Evoked spectral power (μV) 
Decreased spectral power of 
unaffected siblings compared with 
healthy controls 
↓ -1.135 
Rass, Forsyth et al. 
(2012) 
First degree relatives 
of schizophrenia 
patients 
35 56 Auditory steady 
state response 
Mean trial power (change 
from baseline) 
Decreased meant trial power in 
relatives compared with healthy 
controls.  
↓ -0.733 
Rass, Forsyth et al. 
(2012) 
First degree relatives 
of schizophrenia 
patients 
35 56 Auditory steady 
state response Phase locking factor 
Decreased phase locking factor in 
relatives compared with healthy 
controls. No significant group effect 
(F statistic and p value not 
reported). 
↓ N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Right temporal 
spontaneous spectral 
power in the 30-50Hz band 
Spectral power in the right temporal 
region significantly higher in 
relatives compared with healthy 
controls. 
↑  N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Right parietal spontaneous 
spectral power in the 50-
70Hz band 
Spectral power in the right parietal 
higher in relatives compared with 
healthy controls.  
↑  N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Right temporal 
spontaneous spectral 
power in the 50-70Hz band 
Spectral power in the right temporal 
significantly higher in relatives 
compared with healthy controls.  
↑  N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Right parietal spontaneous 
spectral power in the 70-
100Hz band 
Spectral power in the right parietal 
higher in relatives compared with 
healthy controls 
↑  N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Right temporal 
spontaneous spectral 
power in the 70-100Hz 
band 
Spectral power in the right temporal 
significantly higher in relatives 
compared with healthy controls 
↑  N/A 
Tikka, Nizamie et al. 
(2015) 
First degree relatives 
of schizophrenia 
patients 
30 30 Resting state, 
eyes closed 
Inter hemispheric cross 
spectral coherence 
No statistically significant 
differences in inter- or intra-
hemispheric coherence between 
relatives and healthy controls 
 N/A 
Venables, Bernat et 
al. (2009) 
First degree relatives 
of schizophrenia 
patients 
61 79 Resting state, 
eyes open Spontaneous power (μV2) 
Increased power at anterior  
and temporal sites in relatives 
compared with controls. 
 
↑  N/A 
Winterer, Egan et 
al. (2001) 
Siblings of patients 
with schizophrenia, 
with no lifetime history 
of psychotic disorder  
166 58 Resting state, 
eyes closed Spontaneous power (μV) 
No difference between groups, 
however means, F statistics and p 
values not reported 
 N/A 
Winterer, Egan et 
al. (2001) 
Siblings of patients 
with schizophrenia, 
with no lifetime history 
of psychotic disorder 
166 58 
Resting state, 
eyes closed 
Inter-hemispheric power 
coherence 
No difference between groups, 
however means, F statistics and p 
values not reported 
 N/A 
Winterer, Egan et 
al. (2001) 
Siblings of patients 
with schizophrenia, 
with no lifetime history 
of psychotic disorder 
166 58 
Resting state, 
eyes closed 
Intra-hemispheric power 
coherence 
No difference between groups, 
however means, F statistics and p 
values not reported 
 N/A 
Winterer, Coppola 
et al. (2004) 
Unaffected siblings of 
patients with 
schizophrenia 
115 89 Auditory oddball 
task Frontal noise power 
Increased frontal noise power in 
unaffected siblings compared with 
healthy controls 
↑  0.277 
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Table 5. Gamma Oscillations in Schizotypy 
Study Definition of schizotypy 
High 
schizotypy 
Number 
Healthy control / 
low schizotypy 
Number 
Task Measurement of 
gamma Summary of findings 
Direction 
of 
difference 
Hedge’s 
g 
Brenner, Sporns et 
al. (2003) 
Schizotypal personality 
disorder (diagnostic 
instrument not defined) 
11 22 Auditory steady 
state response Evoked power (μV2) 
No difference in power between schizotypal 
personality disorder and non-psychiatric 
controls. 
 N/A 
Fuggetta, Bennett 
et al. (2014) 
Grouped into high and low 
schizotypy groups based 
on answers to Unusual 
Experiences and Cognitive 
Disorganisation sub scales 
of the Oxford-Liverpool 
Inventory of Feelings and 
Experiences 
16 16 Resting state, 
eyes closed 
Relative spectral 
power (%) 
Decreased spectral power in high schizotypy 
individuals compared with low schizotypy 
individuals (non-significant) 
↓ -0.416 
Kornmayer, Leicht 
et al. (2015) 
Healthy volunteers who 
completed the Schizotypal 
Personality Questionnaire  
24 N/A 
Visual reaction 
task with 
physically salient 
distracter 
Evoked spectral 
power (μV2) 
Early evoked visual gamma spectral power 
positively correlated with positive schizotypal 
personality traits 
↑  1.404 
Koychev, Deakin et 
al. (2011) 
Grouped into high and low 
schizotypy groups based 
on answers to the short 
version of the Schizotypal 
Personality Questionnaire 
18 20 Visual working 
memory task Phase locking factor 
Decreased phase locking factor in high 
schizotypy individuals compared with low 
schizotypy individuals 
↓ -0.678 
Koychev, Deakin et 
al. (2011) 
Grouped into high and low 
schizotypy groups based 
on answers to the short 
version of the Schizotypal 
Personality Questionnaire 
18 20 Visual working 
memory task 
Evoked spectral 
power (μV) 
Increased spectral power in high schizotypy 
individuals compared with low schizotypy 
individuals 
↑  0.719 
Skosnik, Krishnan 
et al. (2006) 
Schizotypal personality 
questionnaire 17 N/A 
Auditory steady 
state response 
Evoked Log10 
Spectral power (μV2) 
at Fz 
Negative correlation of schizotypal scores with 
power at 20Hz in cannabis users. No 
correlation within non-cannabis using group or 
at other frequencies. 
↓ N/A 
Tcheslavski (2008) 
Grouped into high and low 
schizotypy groups based 
on answers to the short 
version of the Schizotypal 
Personality Questionnaire 
20 19 Resting state, 
eyes closed 
Average spectral 
power 
Increased gamma average spectral power in 
high schizotypy compared with low schizotypy, 
most pronounced in fronto-central region. 
↑  N/A 
Tcheslavski and 
Beex (2010) 
Grouped into high and low 
schizotypy groups based 
on answers to the short 
version of the Schizotypal 
Personality Questionnaire 
20 20 Resting state, 
eyes closed 
Average phase 
synchrony 
Reported increased phase synchrony in high 
schizotypy smokers compared with low 
schizotypy smokers, as well as high schizotypy 
non-smokers compared with low schizotypy 
non-smokers. For all electrode pairs expect 
C3-F3.  However, no mean values, F statistics 
or p values reported. 
↑  N/A 
Vernon, Haenschel 
et al. (2005) 
Healthy volunteers (n=40), 
separated into high/low 
unreality groups based on 
Personality Schizotypy 
Questionnaire scores 
NR NR Auditory 
habituation task 
Induced spectral 
power (μV) 
Decreased spectral power in individuals with 
high unreality schizotypy scores compared 
with individuals with low unreality scores (non-
significant) 
↓ N/A 
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Table 6. Assessment of Bias 
Study Selection 1 Selection 2 Selection 3 Selection 4 Comparability 1 Exposure 1 Exposure 2 Exposure 3 
Andreou, Leicht et al. 
(2015) 1 0 1 1 2 0 1 1 
Andreou, Nolte et al. 
(2015) 1 0 1 1 1 0 1 1 
Bandyopadhyaya, 
Nizamie et al. (2011) 1 0 0 1 2 0 1 1 
Brenner, Sporns et al. 
(2003) 0 0 1 0 0 0 1 1 
Diez, Suazo et al. 
(2013) 1 0 1 1 0 0 1 1 
Diez, Suazo et al. 
(2014) 0 0 1 1 1 0 1 1 
Donkers, Schwikert et 
al. (2011) 1 0 1 1 2 0 1 0 
Flynn, Alexander et al. 
(2008) 1 0 0 1 0 0 1 1 
Fuggetta, Bennett et 
al. (2014) 1 0 1 1 2 0 1 1 
Gallinat, Winterer et al. 
(2004) 1 0 1 1 2 0 1 1 
Garakh, Zaytseva et al. 
(2015) 1 1 0 0 2 0 1 1 
Hall, Taylor et al. 
(2011a) 1 0 0 1 0 0 1 1 
Hall, Taylor et al. 
(2011b) 1 0 0 1 0 1 1 1 
Hong, Summerfelt et 
al. (2004) 0 0 1 1 2 0 1 1 
Hong, Summerfelt et 
al. (2012) 1 0 1 1 2 0 1 1 
Kikuchi, Koenig et al. 
(2007) 1 0 0 1 2 0 1 1 
Kikuchi, Hashimoto et 
al. (2011) 1 0 0 1 2 0 1 1 
Kornmayer, Leicht et 
al. (2015) 1 0 N/A N/A N/A N/A N/A N/A 
Koychev, Deakin et al. 
(2011) 1 0 1 1 2 0 1 1 
Leicht, Karch et al. 
(2011) 1 0 1 1 0 0 1 1 
Leicht, Vauth et al. 
(2016) 1 1 0 1 2 0 1 1 
Leicht, Andreou et al. 
(2015) 1 0 1 1 2 0 1 1 
Minzenberg, Firl et al. 
(2010) 1 0 1 1 0 0 1 0 
Perez, Roach et al. 
(2013) 1 0 1 1 2 0 1 1 
Ramyead, Kometer et 
al. (2015) 1 1 0 1 0 0 1 1 
Ramyead, Studerus et 
al. (2015) 1 1 N/A N/A N/A N/A N/A N/A 
Ramyead, Studerus et 
al. (2016) 
1 1 1 1 0 0 1 1 
Rass, Forsyth et al. 
(2012) 1 0 1 1 1 0 1 1 
Skosnik, Krishnan et 
al. (2006) 1 0 N/A N/A N/A N/A N/A N/A 
Slewa-Younan, 
Gordon et al. (2004) 1 0 0 1 1 0 1 1 
Spencer, Salisbury et 
al. (2008) 1 0 1 1 2 0 1 0 
Symond, Harris et al. 
(2005) 1 0 0 0 2 0 1 1 
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Study Selection 1 Selection 2 Selection 3 Selection 4 Comparability 1 Exposure 1 Exposure 2 Exposure 3 
Tada, Nagai et al. 
(2014) 1 0 0 1 2 0 1 1 
Taylor, McCarley et al. 
(2013) 1 0 1 1 2 0 1 1 
Tcheslavski (2008) 1 0 1 1 1 0 1 1 
Tcheslavski and Beex 
(2010) 1 0 1 1 1 0 1 1 
Tikka, Yadav et al. 
(2014) 1 0 0 0 2 1 1 0 
Tikka, Nizamie et al. 
(2015) 1 0 0 1 1 1 1 1 
Venables, Bernat et al. 
(2009) 1 0 1 1 2 0 1 0 
Vernon, Haenschel et 
al. (2005) 1 0 1 1 0 0 1 1 
Williams, Whitford et 
al. (2009a) 1 0 0 1 2 0 1 1 
Williams, Whitford et 
al. (2009b) 1 0 0 1 2 0 1 1 
Winterer, Egan et al. 
(2001) 1 0 1 1 0 1 1 1 
Winterer, Coppola et 
al. (2004)  1 0 1 1 0 1 1 1 
Yeragani, Cashmere et 
al. (2006) 1 1 1 0 1 1 1 1 
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Table 7. Assessment of Gamma Artefact Correction 
Study Powerline Noise EMG Artefact Saccadic Muscle Artefact Scores 
Andreou, Leicht et al. (2015) Electrically shielded ICA  ICA  3 
Andreou, Nolte et al. (2015) Electrically shielded ICA  ICA  3 
Bandyopadhyaya, Nizamie et 
al. (2011) 
Not addressed Instructed to relax Not addressed 0 
Brenner, Sporns et al. (2003) Not addressed Manually removed Manually removed 0 
Diez, Suazo et al. (2013) Not addressed Manually removed Manually removed 0 
Diez, Suazo et al. (2014) Not addressed Manually removed Manually removed 0 
Donkers, Schwikert et al. (2011) Notch filter Not addressed Not addressed 1 
Flynn, Alexander et al. (2008) Not addressed Not addressed Not addressed 0 
Fuggetta, Bennett et al. (2014) Notch filter Instructed to relax Not addressed 1 
Gallinat, Winterer et al. (2004) Electrically shielded and notch 
filter 
Manually removed Manually removed 1 
Garakh, Zaytseva et al. (2015) Not addressed Automated removal Automated removal 2 
Hall, Taylor et al. (2011a) Not addressed Manually removed Manually removed 0 
Hall, Taylor et al. (2011b) Not addressed Manually removed Manually removed 0 
Hong, Summerfelt et al. (2004) Not addressed Instructed to relax Manually removed 0 
Hong, Summerfelt et al. (2012) Not addressed Not addressed Automated removal 1 
Kikuchi, Koenig et al. (2007) Not addressed Instructed to relax, artefact 
manually removed 
Manually removed 0 
Kikuchi, Hashimoto et al. (2011) Not addressed Instructed to relax, artefact 
manually removed 
Manually removed 0 
Kornmayer, Leicht et al. (2015) Electrically shielded ICA and algorithm based on 
power spectrum 
ICA and algorithm based on 
power spectrum 
3 
Koychev, Deakin et al. (2011) Not addressed Not addressed Not addressed 1 
Leicht, Karch et al. (2011) Electrically shielded Not addressed Not addressed 1 
Leicht, Vauth et al. (2016) Active electrodes, notch filter ICA ICA 3 
Leicht, Andreou et al. (2015) Electrically shielded, active 
electrodes 
Manually removed Manually removed 1 
Minzenberg, Firl et al. (2010) Electrically shielded ICA  ICA  3 
Perez, Roach et al. (2013) Not addressed Not addressed Not addressed 0 
Ramyead, Kometer et al. (2015) Not addressed ICA  ICA  2 
Ramyead, Studerus et al. 
(2015) 
Not addressed ICA  ICA  2 
Ramyead, Studerus et al. 
(2016) 
Not addressed ICA  ICA  2 
Rass, Forsyth et al. (2012) Not addressed Not addressed Not addressed 0 
Skosnik, Krishnan et al. (2006) Not addressed Not addressed Not addressed 0 
Slewa-Younan, Gordon et al. 
(2004) 
Notch filter Not addressed Not addressed 1 
Spencer, Salisbury et al. (2008) Not addressed Not addressed Not addressed 0 
Symond, Harris et al. (2005) Not addressed Not addressed Not addressed 0 
Tada, Nagai et al. (2014) Electrically shielded, notch filter Not addressed Not addressed 1 
Taylor, McCarley et al. (2013) Not addressed Not addressed Not addressed 0 
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Study Powerline Noise EMG Artefact Saccadic Muscle Artefact Scores 
Tcheslavski (2008) Not addressed Not addressed Not addressed 0 
Tcheslavski and Beex (2010) Not addressed Not addressed Not addressed 0 
Tikka, Yadav et al. (2014) Not addressed Manually removed Manually removed 0 
Tikka, Nizamie et al. (2015) Not addressed Manually removed Manually removed 0 
Venables, Bernat et al. (2009) Not addressed Not addressed Not addressed 0 
Vernon, Haenschel et al. (2005) Not addressed Manually removed Manually removed 0 
Williams, Whitford et al. (2009a) Notch filter Not addressed Not addressed 1 
Williams, Whitford et al. (2009b) Not addressed Not addressed Not addressed 0 
Winterer, Egan et al. (2001) Not addressed Manually removed Manually removed 0 
Winterer, Coppola et al. (2004) Not addressed Manually removed Manually removed 0 
Yeragani, Cashmere et al. 
(2006) 
Notch filter Not addressed Not addressed 1 
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